Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWMinosaminomycin is an antibiotic that has been found in Streptomyces.1 It is active against M. smegmatis and M. phlei (MICs = 1.56 and 6.25 µg/ml, respectively). Minosaminomycin (1 µM) inhibits the binding of formyl-Met-tRNA (fMet-tRNA) to ribosomes in the presence of the AUG trinucleotide by 96% in a cell-free assay and inhibits Mycobacterium protein synthesis when used at a concentration of 100 µM.2
WARNING This product is not for human or veterinary use.
1. Letter: Minosaminomycin, a new antibiotic containing myo-
2. Biochemical study of minosaminomycin in relation to the kasugamycin group antibiotics. J. Antibiot. (Tokyo) 30(2), 132-140 (1977).